Clinical Trial Update: Study of DA-9801 to Treat Diabetic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for DA-9801 in diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• DA-9801

Snippet

Sponsor: NeuroBo Pharmaceuticals Inc. | Conditions: Diabetic Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2020-03-20